Aromasin and hepatic failure Patient Reports February 11, 2012

Aromasin Side Effects Report #5450339-6
Aromasin side effect was reported by a Physician from GERMANY on Aug 31, 2007. Female patient, weighting 125.7 lb, was diagnosed with breast cancer metastatic and was treated with Aromasin. After drug was administered, patient experienced the following side effects: hepatic failure. Aromasin dosage: unknown. During the same period patient was treated with PAMIDRONATE DI, ZOMETA. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5478871-X
Aromasin side effect was reported by a Physician from GERMANY on Sept 25, 2007. Female patient, weighting 125.7 lb, was diagnosed with breast cancer metastatic, bone pain and was treated with Aromasin. After drug was administered, patient experienced the following side effects: hepatic failure, rash . Aromasin dosage: unknown. During the same period patient was treated with KATADOLON, PAMIDRONATE DI, ZOMETA, ARIMIDEX. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5493985-6
Aromasin side effect was reported by a Physician from GERMANY on Oct 11, 2007. Female patient, weighting 125.7 lb, was diagnosed with breast cancer metastatic, bone pain and was treated with Aromasin. After drug was administered, patient experienced the following side effects: hepatic failure, rash . Aromasin dosage: unknown. During the same period patient was treated with KATADOLON, PAMIDRONATE DI, ZOMETA, ARIMIDEX. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5526896-8
Aromasin side effect was reported by a Physician from GERMANY on Nov 15, 2007. Female patient, weighting 125.7 lb, was diagnosed with breast cancer metastatic, bone pain and was treated with Aromasin. After drug was administered, patient experienced the following side effects: ascites, febrile infection, hepatic failure, rash . Aromasin dosage: unknown. During the same period patient was treated with KATADOLON, PAMIDRONATE DI, ZOMETA, ARIMIDEX. Patient was hospitalized. Patient recovered.


Aromasin Side Effects Report #5602986-6
Aromasin side effect was reported by a Physician from GERMANY on Jan 15, 2008. Female patient, weighting 125.7 lb, was diagnosed with breast cancer metastatic, bone pain and was treated with Aromasin. After drug was administered, patient experienced the following side effects: ascites, hepatic failure, nasopharyngitis. Aromasin dosage: unknown. During the same period patient was treated with KATADOLON, PAMIDRONATE DI, ZOMETA, ARIMIDEX. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5649572-X
Aromasin side effect was reported by a Physician from GERMANY on Feb 21, 2008. Female patient, weighting 125.7 lb, was diagnosed with breast cancer metastatic, bone pain and was treated with Aromasin. After drug was administered, patient experienced the following side effects: ascites, hepatic failure, nasopharyngitis, neoplasm progression. Aromasin dosage: unknown. During the same period patient was treated with KATADOLON, PAMIDRONATE DI, ZOMETA, ARIMIDEX. Patient was hospitalized. Patient died.

Aromasin Side Effects Report #5763000-5
Aromasin side effect was reported by a Physician from GERMANY on May 28, 2008. Female patient, weighting 125.7 lb, was diagnosed with breast cancer metastatic, bone pain and was treated with Aromasin. After drug was administered, patient experienced the following side effects: ascites, hepatic failure, nasopharyngitis, neoplasm progression. Aromasin dosage: unknown. During the same period patient was treated with KATADOLON, PAMIDRONATE DI, ZOMETA, ARIMIDEX. Patient was hospitalized. Patient died on 01/15/2008.

Aromasin Side Effects Report #4998544-7
Aromasin side effect was reported by a Physician from JAPAN on Apr 25, 2006. Female patient, 69 years of age, weighting 108.0 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: anaemia, hepatic failure, hepatic function abnormal, movement disorder , pyrexia. Aromasin dosage: 25 MG (25 MG, DAILY), ORAL. During the same period patient was treated with VINORELBINE TARTRATE, EPIRUBICIN, CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient died on 03/01/2006.

Aromasin Side Effects Report #5809715-1
Aromasin side effect was reported by a Health Professional from UNITED STATES on July 11, 2008. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cholecystitis chronic, hepatic failure, hepatitis cholestatic, open wound. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.


Aromasin Side Effects Report #5811492-5
Aromasin side effect was reported by a Health Professional from UNITED STATES on July 14, 2008. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cholecystitis chronic, hepatic failure, hepatitis cholestatic, open wound, scratch, weight decreased. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5812965-1
Aromasin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 15, 2008. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cholecystitis chronic, fatigue, hepatic failure, open wound, vomiting, weight decreased. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5818732-7
Aromasin side effect was reported by a Health Professional from UNITED STATES on July 17, 2008. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: cholecystitis chronic, fatigue, hepatic failure, hepatitis cholestatic, open wound, pruritus, vomiting, weight decreased. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5828590-2
Aromasin side effect was reported by a Health Professional from UNITED STATES on July 29, 2008. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: agitation, cholecystitis chronic, hepatic failure, hepatitis cholestatic, open wound, scratch. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5903196-5
Aromasin side effect was reported by a Health Professional from UNITED STATES on Sept 29, 2008. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: agitation, cholecystitis chronic, hepatic failure, hepatitis cholestatic, open wound, scar , scratch. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROXEN. Patient was hospitalized. Patient recovered.


Aromasin Side Effects Report #5918476-7
Aromasin side effect was reported by a Health Professional from UNITED STATES on Oct 14, 2008. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: hepatic failure, hepatic function abnormal, hepatitis cholestatic, liver function test abnormal, open wound, scar , scratch, skin hyperpigmentation, weight decreased. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5931242-1
Aromasin side effect was reported by a Health Professional from UNITED STATES on Oct 24, 2008. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: agitation, antimitochondrial antibody positive, cholecystitis chronic, hepatic failure, hepatitis cholestatic, open wound, scar , skin hyperpigmentation. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #5963700-8
Aromasin side effect was reported by a Health Professional from UNITED STATES on Nov 21, 2008. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: agitation, antimitochondrial antibody positive, cholecystitis chronic, excoriation, hepatic failure, hepatitis cholestatic, pruritus, vomiting, weight decreased. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #6061022-0
Aromasin side effect was reported by a Health Professional from UNITED STATES on Jan 29, 2009. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: agitation, antimitochondrial antibody positive, excoriation, fatigue, hepatic failure, hepatitis cholestatic, jaundice , open wound, pruritus. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.

Aromasin Side Effects Report #6067425-2
Aromasin side effect was reported by a Health Professional from UNITED STATES on Feb 04, 2009. Female patient, weighting 158.7 lb, was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: agitation, antimitochondrial antibody positive, cholecystitis chronic, excoriation, hepatic failure, hepatitis cholestatic, open wound, scar , skin hyperpigmentation. Aromasin dosage: 25 MG QD PO. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.


Aromasin Side Effects Report #4837935-1
Aromasin side effect was reported by a Physician from INDIA on Nov 12, 2005. Female patient was diagnosed with breast cancer  and was treated with Aromasin. After drug was administered, patient experienced the following side effects: hepatic failure. Aromasin dosage: 25 MG (25 MG, DAILY), ORAL. During the same period patient was treated with ANTIHYPERTENSIVES. Patient died on 10/10/2005.